Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M90.1Revenue $M41.1Net Margin (%)--Altman Z-Score42.6
Enterprise Value $M50.7EPS $-0.3Operating Margin %--Piotroski F-Score3
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book2.510-y EBITDA Growth Rate %--Quick Ratio32.8Cash flow > EarningsY
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio32.8Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %-142.6ROA % (ttm)-26.6Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-27.6Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M45.8ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with PTIE

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PTIEMario Gabelli 2015-03-31 Reduce$1.66 - $2.12
($1.93)
$ 1.972%Reduce 17.65%70,000
PTIEMario Gabelli 2014-09-30 Reduce$3.6 - $5.72
($4.32)
$ 1.97-54%Reduce 33.33%100,000
PTIEFirst Eagle Investment 2014-06-30 Add0.01%$4.58 - $6.06
($5.28)
$ 1.97-63%Add 22.14%4,474,735
PTIEGeorge Soros 2014-06-30 Sold Out -0.01%$4.58 - $6.06
($5.28)
$ 1.97-63%Sold Out0
PTIEFirst Eagle Investment 2014-03-31 Add0.01%$3.92 - $5.71
($5.03)
$ 1.97-61%Add 25.15%3,663,750
PTIEGeorge Soros 2014-03-31 Buy 0.01%$3.92 - $5.71
($5.03)
$ 1.97-61%New holding103,700
PTIEFirst Eagle Investment 2013-12-31 Add0.01%$2.61 - $4.73
($3.79)
$ 1.97-48%Add 20.37%2,927,386
PTIEMario Gabelli 2013-12-31 Reduce$2.61 - $4.73
($3.79)
$ 1.97-48%Reduce 24.00%190,000
PTIEFirst Eagle Investment 2013-09-30 Add$2.21 - $3.11
($2.5)
$ 1.97-21%Add 30.60%2,431,935
PTIEFirst Eagle Investment 2013-06-30 Add0.01%$2.21 - $5.41
($3.02)
$ 1.97-35%Add 171.01%1,862,099
PTIEFirst Eagle Investment 2013-03-31 Add$2.47 - $3.74
($3.01)
$ 1.97-35%Add 30.53%687,099
PTIEFirst Eagle Investment 2012-12-31 Add$2.42 - $5.83
($3.66)
$ 1.97-46%Add 163.20%526,408
PTIEFirst Eagle Investment 2012-09-30 Buy $3.57 - $5.29
($4.22)
$ 1.97-53%New holding200,000
PTIEMario Gabelli 2011-03-31 Reduce-0.04%$6.05 - $9.72
($7.13)
$ 1.97-72%Reduce 53.97%480,000
PTIEMario Gabelli 2010-09-30 Add0.02%$5.26 - $6.49
($5.76)
$ 1.97-66%Add 111.68%1,047,800
PTIEMario Gabelli 2010-06-30 Reduce-0.01%$5.32 - $6.6
($5.87)
$ 1.97-66%Reduce 50.93%495,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PTIE is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


PTIE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ROBERTSON SANFORDDirector 2013-11-06Buy50,000$3.73-47.18view
FRIEDMANN NADAVCOO 2011-10-18Sell25,000$4.44-55.63view
FRIEDMANN NADAVCOO 2011-10-04Sell25,000$4.81-59.04view
Sabretooth Master Fund, L.P.10% Owner 2011-10-04Sell382,000$4.59-57.08view
FRIEDMANN NADAVCOO 2011-09-15Sell25,000$4.89-59.71view
Sabretooth Master Fund, L.P.10% Owner 2011-08-08Sell44,417$4.2-53.1view
BARBIER REMICEO, Chairman of the Board, 10% Owner 2011-08-08Buy5,000$4.22-53.32view
BARBIER REMICEO & Chairman of the Board, 10% Owner 2010-10-04Sell50,000$6.2-68.23view
BARBIER REMICEO & Chairman of the Board, 10% Owner 2010-09-07Sell28,597$5.69-65.38view
BARBIER REMICEO & Chairman of the Board, 10% Owner 2010-09-02Sell21,403$5.81-66.09view

Press Releases about PTIE :

    Quarterly/Annual Reports about PTIE:

    News about PTIE:

    Articles On GuruFocus.com
    Wednesday Pre-Market Insights: GEVO, WPZ, HDP, PTIE May 13 2015 
    Eveillard's First Eagle Increases 2 Positions Sep 11 2014 
    Morning Coffee: Real-Time Picks May 14 2014 
    Pain Therapeutics Reports Operating Results (10-K) Feb 03 2011 
    Pain Therapeutics Reports Operating Results (10-Q) Oct 29 2010 
    Pain Therapeutics (PTIE) CEO & Chairman of the Board, 10% Owner Remi Barbier sells 50,000 Shares Oct 04 2010 
    Pain Therapeutics (PTIE) CEO & Chairman of the Board, 10% Owner Remi Barbier sells 28,597 Shares Sep 08 2010 
    Pain Therapeutics (ptie) CEO & Chairman of the Board, 10% Owner Remi Barbier sells 21,403 Shares Sep 02 2010 
    Pain Therapeutics (PTIE) CEO & Chairman of the Board, 10% Owner Remi Barbier sells 22,391 Shares Aug 04 2010 
    Pain Therapeutics Reports Operating Results (10-Q) Jul 29 2010 

    More From Other Websites
    PAIN THERAPEUTICS INC Financials May 20 2015
    PAIN THERAPEUTICS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 14 2015
    5 New Biotech Developments Worth Watching May 13 2015
    Why This Study May Have Saved Pain Therapeutics May 12 2015
    Pain Therapeutics Announces Positive Top-Line Results From Human Abuse Potential Study With REMOXY May 12 2015
    PAIN THERAPEUTICS INC Files SEC form 8-K, Other Events May 12 2015
    Pain Therapeutics Announces Positive Top-Line Results From Human Abuse Potential Study With REMOXY May 12 2015
    Pain Therapeutics Announces Update on Drug Portfolio May 11 2015
    10-Q for Pain Therapeutics, Inc. May 11 2015
    Pain Therapeutics Announces Update on Drug Portfolio May 11 2015
    PAIN THERAPEUTICS INC Files SEC form 10-Q, Quarterly Report May 08 2015
    Pain Therapeutics Reports Q1 2015 Financial Results May 07 2015
    Pain Therapeutics reports 1Q loss May 07 2015
    Pain Therapeutics reports 1Q loss May 07 2015
    PAIN THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition May 07 2015
    Pain Therapeutics Reports Q1 2015 Financial Results May 07 2015
    PAIN THERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events May 06 2015
    Pain Therapeutics Announces Appointment of Senior Vice President, Regulatory Affairs Apr 23 2015
    Pain Therapeutics Announces Appointment of Senior Vice President, Regulatory Affairs Apr 23 2015
    Pain Therapeutics Resumes Responsibility for REMOXY Apr 21 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK